Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Siponimod vs placebo in secondary progressive multiple sclerosis
CTR20140407Phase 3Terminated
- Sponsor
- Novartis
- Start
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of siponimod in secondary-progressive multiple sclerosis (SPMS), sponsored by Novartis. Started Jun 2014; status: terminated.
02
Drugs
siponimod
03
Conditions
secondary-progressive multiple sclerosis (SPMS)
Beyond the preview
Go deeper on CTR20140407.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140407.